首页>
外国专利>
Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations
Compositions and the use of interleukin-2 and/or interferon-beta and tumour necrosis factor for combination therapy or in providing medicaments or formulations
展开▼
机译:白细胞介素2和/或干扰素-β和肿瘤坏死因子的组合及其在联合治疗中或在提供药物或制剂中的用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
Anti-tumor activity in mammals can be augmented by administering to the mammalian host a synergistically effective amount of TNF and IL-2 or of TNF and IFN- beta , or of TNF, IL-2 and ITN- beta in combination. The composition of TNF and IL-2 and/or IFN- beta may be prepared in vitro or administered separately to the host. If the TNF and IL-2 are administered sequentially, the TNF must be administered prior to the IL-2 to obtain synergy. The composition is useful for treating such cancers as mastocytoma, melanoma, leukemia, and lymphoma.
展开▼